Ainos Investor Relations Material

Ainos is a biopharmaceutical company engaged in the development of medical technologies for point-of-care testing and novel medical treatments. The Company focuses on the discovery, development and commercialization of novel therapeutic products by conducting research and preclinical studies, developing new models to accelerate drug discovery, expanding its commercial presence internationally and targeting high mortality diseases with unmet needs.